In Brief: Bioresearch regulations
This article was originally published in The Gray Sheet
Bioresearch regulations: FDA public workshop on regulatory requirements for the bioresearch industry is slated for Sept. 24 at the University Hospital at the University of Alabama, Birmingham. Many bioresearch firms "are either unaware of applicable regulations and guidelines or not in compliance with applicable requirements," FDA notes in a Sept. 4 Federal Register notice announcing the meeting. For further information on the workshop, contact William Oates in FDA's Nashville District Office at 615/781-5374...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.